SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-027050
Filing Date
2022-11-14
Accepted
2022-11-14 08:00:17
Documents
30
Period of Report
2022-11-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20221110_8k.htm   iXBRL 8-K 23763
2 EXHIBIT 99.1 ex_445769.htm EX-99.1 9530
7 mbrx20221110_8kimg001.jpg GRAPHIC 4001
8 s01.jpg GRAPHIC 76010
9 s02.jpg GRAPHIC 87572
10 s03.jpg GRAPHIC 49818
11 s04.jpg GRAPHIC 61658
12 s05.jpg GRAPHIC 80537
13 s06.jpg GRAPHIC 65761
14 s07.jpg GRAPHIC 75054
15 s08.jpg GRAPHIC 67474
16 s09.jpg GRAPHIC 80187
17 s10.jpg GRAPHIC 62056
18 s11.jpg GRAPHIC 60922
19 s12.jpg GRAPHIC 55553
20 s13.jpg GRAPHIC 73091
21 s14.jpg GRAPHIC 29303
22 s15.jpg GRAPHIC 64521
  Complete submission text file 0001437749-22-027050.txt   1538054

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20221110.xsd EX-101.SCH 3603
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20221110_def.xml EX-101.DEF 11534
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20221110_lab.xml EX-101.LAB 15416
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20221110_pre.xml EX-101.PRE 11690
24 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20221110_8k_htm.xml XML 2562
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 221380404
SIC: 2834 Pharmaceutical Preparations